Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Esophageal Stent With or Without Anti-migration Device for Tumors of the Gastroesophageal Junction: Multicenter Randomized Controlled Study. ANTIMIG Study

NCT05431738 is registered in ClinicalTrials.gov with Société Française d'Endoscopie Digestive as lead sponsor.

NCT NCT05431738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05431738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Esophageal Stent With or Without Anti-migration Device for Tumors of the Gastroesophageal Junction: Multicenter Randomized Controlled Study. ANTIMIG Study
Lead sponsor
Société Française d'Endoscopie Digestive
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2022
Completion date
September 1, 2025
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal cancer, stent migration